2001
DOI: 10.1016/s0140-6736(01)05966-9
|View full text |Cite
|
Sign up to set email alerts
|

Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

9
235
1
20

Year Published

2004
2004
2019
2019

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 385 publications
(265 citation statements)
references
References 22 publications
9
235
1
20
Order By: Relevance
“…DA, NE, and ACh antagonists degrade practice-dependent plasticity in healthy subjects (Sawaki et al, , 2003Meintzschel and Ziemann, 2006), and retrospective studies strongly suggest that these NMDs are also detrimental in sensorimotor recovery after cerebral stroke (Goldstein et al, 1990;Goldstein, 1995). Conversely, DA, NE, and ACh agonists facilitate practice-dependent plasticity in healthy subjects Flöel et al, 2005a;Meintzschel and Ziemann, 2006) and may be beneficial in stroke rehabilitation (Crisostomo et al, 1988;Walker-Batson et al, 1995;Grade et al, 1998;Scheidtmann et al, 2001;Berthier et al, 2003;Flöel et al, 2005b;Zittel et al, 2007) although this evidence is not undisputed (for review, see Rösser and Flöel, 2008;Berends et al, 2009). The congruence of suppressive effects of NMDs on PASinduced LTP-like plasticity and practice-dependent plasticity suggests that PAS-induced LTP-like plasticity may serve as a biological marker for unfavorable drug effects on motor learning and recovery.…”
Section: Clinical Perspectivementioning
confidence: 99%
“…DA, NE, and ACh antagonists degrade practice-dependent plasticity in healthy subjects (Sawaki et al, , 2003Meintzschel and Ziemann, 2006), and retrospective studies strongly suggest that these NMDs are also detrimental in sensorimotor recovery after cerebral stroke (Goldstein et al, 1990;Goldstein, 1995). Conversely, DA, NE, and ACh agonists facilitate practice-dependent plasticity in healthy subjects Flöel et al, 2005a;Meintzschel and Ziemann, 2006) and may be beneficial in stroke rehabilitation (Crisostomo et al, 1988;Walker-Batson et al, 1995;Grade et al, 1998;Scheidtmann et al, 2001;Berthier et al, 2003;Flöel et al, 2005b;Zittel et al, 2007) although this evidence is not undisputed (for review, see Rösser and Flöel, 2008;Berends et al, 2009). The congruence of suppressive effects of NMDs on PASinduced LTP-like plasticity and practice-dependent plasticity suggests that PAS-induced LTP-like plasticity may serve as a biological marker for unfavorable drug effects on motor learning and recovery.…”
Section: Clinical Perspectivementioning
confidence: 99%
“…2 Importantly, and in contrast to the many failed clinical trails using neuroprotective strategies, pharmacological enhancement of brain plasticity has shown efficacy in small clinical trials. 3 Hence, elucidating the fundamental processes regulating or affecting brain plasticity after stroke could provide new therapies that would enhance recovery after stroke for the benefit of a majority of stroke patients.…”
Section: Introductionmentioning
confidence: 99%
“…Dopamine seems to be effective not only in enhancing working memory in healthy subjects (Barch, 2004) and ameliorating cognitive deficits in the early stages of Parkinson's disease (eg Kulisevsky, 2000) but also in motor recovery after stroke in humans (Scheidtmann et al, 2001) and in boosting of language learning in healthy subjects (Knecht et al, 2004). Even though a small fraction (o5%) of levodopa is hydroxylated to norepinephrine (Nutt and Fellman, 1984), the cardiovascular and plasticity effects of AMPH could thus be dissociated on a molecular level, with the dopamine effects being relevant for brain plasticity.…”
Section: Introductionmentioning
confidence: 99%